title: Two candidate downstream target genes for E2A-HLF.
abstract: The E2A-HLF fusion gene, formed by the t(17;19)(q22;p13) chromosomal translocation, is thought to drive the leukemic transformation of early B-cell precursors by repressing an evolutionarily conserved apoptotic pathway. To test this hypothesis, we sought to identify downstream targets of E2A-HLF in t(17;19)+ pro-B leukemia cells (UOC-B1) that had been transfected with a zinc-inducible vector encoding a dominant-negative suppressor (E2A-HLF[dn]) of the oncoprotein. Representational difference analysis of mRNAs from E2A-HLF(dn)+ UOC-B1 cells grown with (E2A-HLF inactive) or without (E2A-HLF active) the addition of zinc yielded several differentially expressed cDNA fragments that were individually subcloned. Two of the clones, designated F-5 and G-4, hybridized with mRNAs that were upregulated by E2A-HLF. Levels of both transcripts declined sharply within 8 to 12 hours after suppression of E2A-HLF DNA-binding activity, becoming undetectable after 96 hours. The F-5 cDNA was identified as a portion of ANNEXIN VIII, whose product was expressed in promyelocytic leukemia cells and UOC-B1 cells, but not in other leukemic cell lines. A novel full-length cDNA cloned with the G-4 fragment encoded a protein that we have named SRPUL (sushi-repeat protein upregulated in leukemia). It is normally expressed in heart, ovary, and placenta, but could not be detected in leukemic cell lines other than UOC-B1. Neither protein prevented apoptosis in interleukin-3-dependent murine pro-B cells, suggesting that they have paraneoplastic roles in leukemias that express E2A-HLF, perhaps in the disseminated intravascular coagulopathy and hypercalcemia that characterize these cases.
authors.affiliation: Department of Experimental Oncology and the Center for Biotechnology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
authors.forename: H
authors.initials: H
authors.lastname: Kurosawa
authors.forename: K
authors.initials: K
authors.lastname: Goi
authors.forename: T
authors.initials: T
authors.lastname: Inukai
authors.forename: T
authors.initials: T
authors.lastname: Inaba
authors.forename: K S
authors.initials: KS
authors.lastname: Chang
authors.forename: T
authors.initials: T
authors.lastname: Shinjyo
authors.forename: K M
authors.initials: KM
authors.lastname: Rakestraw
authors.forename: C W
authors.initials: CW
authors.lastname: Naeve
authors.forename: A T
authors.initials: AT
authors.lastname: Look
mesh_terms: D000595:Amino Acid Sequence; D017302:Annexins / Q000235:genetics; D017209:Apoptosis; D002460:Cell Line; D003001:Cloning, Molecular; D004268:DNA-Binding Proteins / Q000235:genetics*; D052138:Genes, Neoplasm; D006801:Humans; D008565:Membrane Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics*; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D020449:Repetitive Sequences, Amino Acid; D019087:Selectins / Q000737:chemistry / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics; D014407:Tumor Cells, Cultured
chemical_list: D017302:Annexins; D004268:DNA-Binding Proteins; C076554:E2a-Hlf fusion protein, human; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; C116881:SRPX2 protein, human; D019087:Selectins; D014157:Transcription Factors